Ani Pharmaceuticals (ANIP) Preferred Dividend Payments (2012 - 2025)

Ani Pharmaceuticals has disclosed Preferred Dividend Payments across 7 years of filings, most recently posting $344000.0 for Q3 2025.

• Preferred Dividend Payments for Q3 2025 came in at $344000.0, down 15.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $751000.0 (down 53.78% YoY), and the FY2025 annual result was $1.2 million, down 28.8% from the prior year.
• Preferred Dividend Payments came in at $344000.0 for Q3 2025 at Ani Pharmaceuticals, down from $407000.0 in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $407000.0 in Q2 2022 to a low of $190000.0 in Q4 2021.
• The 5-year median for Preferred Dividend Payments is $406000.0 (2022), against an average of $388875.0.
• Across the five-year window, Preferred Dividend Payments surged 114.21% in 2022 and decreased 15.27% in 2025, its largest moves.
• Ani Pharmaceuticals' Preferred Dividend Payments stood at $190000.0 in 2021, then jumped by 114.21% to $407000.0 in 2022, then decreased by 0.25% to $406000.0 in 2023, then changed by 0.0% to $406000.0 in 2024, then retreated by 15.27% to $344000.0 in 2025.
• The last three Preferred Dividend Payments figures came in at $344000.0 (Q3 2025), $407000.0 (Q2 2025), and $406000.0 (Q1 2025), per Business Quant data.